BES completes $4.8m refurb for Recipharm
Recipharm extends commercial manufacturing for RedHill’s drug
What does 2023 hold for oral solid dosage forms?
Recipharm bolsters blow-fill-seal capabilities with Lab+
Managing the next pandemic: how prepared are we?
Transpire Bio announces agreement with Recipharm for the development of an inhaled medicine
Recipharm expands services for pMDI propellants
Recipharm completes two acquisitions
Recipharm invests in high-speed filling line for aseptics
Recipharm expands ATMPs capabilities with CDMO acquisition
Recipharm acquires Portuguese CDMO for biologics capabilities
Recipharm begins construction of vaccine facility in Morocco
Recipharm signs deal for vaccine filling at Kayserberg
Recipharm sells Fontaine-lès-Dijon site to Astrea
The Manufacturing Chemist oral solid dosage roundtable: part II